A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/26/1997	EP0808351A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
11/26/1997	EP0808332A1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions
11/26/1997	EP0808331A1 Chromatographic purification of vancomycin hydrochloride by the use of preparative hplc
11/26/1997	EP0808330A1 A process for preparing certain aza cyclohexapeptides
11/26/1997	EP0808329A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997	EP0808328A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997	EP0808327A1 Proline derivatives useful as inhibitors of human leukocyte elastase
11/26/1997	EP0808326A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
11/26/1997	EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808203A1 Centrifuge with annular filter
11/26/1997	EP0808174A1 Medicament in particle form
11/26/1997	EP0808172A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
11/26/1997	EP0808171A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
11/26/1997	EP0808170A1 Treatment of diabetic neuropathy
11/26/1997	EP0808169A1 Programmed cell death genes and proteins
11/26/1997	EP0808165A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
11/26/1997	EP0808164A1 Method for treatment of obesity using prolactin modulators and diet
11/26/1997	EP0808162A2 Use of carbazole compounds for the treatment of congestive heart failure
11/26/1997	EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
11/26/1997	EP0808103A1 Protein hydroxylation inhibitors for fibroproliferative disorders
11/26/1997	EP0755451A4 Materials and methods for management of hyperacute rejection in human xenotransplantation
11/26/1997	EP0662130B1 A method of producing hepatocyte growth factor and a cell line
11/26/1997	EP0580829B1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract
11/26/1997	EP0548095B1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax
11/26/1997	EP0482176B1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/26/1997	CN1165654A Combination therapy to treat osteoporosis-polyphosphonates or progesting and extrogen agonists
11/26/1997	CN1036532C Process for preparing non-glycosylated recombining human IL2 in reduced form
11/26/1997	CN1036522C Improved meningococcal polysaccharide conjugate vaccine
11/26/1997	CN1036504C Improved meningococoal polysaccharide conjugate vaccine prepn. method
11/25/1997	US5691461 Oligonucleotides inhibiting candida germ tube formation
11/25/1997	US5691460 Epidermal surface antigen gene
11/25/1997	US5691455 Gonadotropins with non-native disulfide bridges
11/25/1997	US5691453 Blood substitutes
11/25/1997	US5691452 Method for preserving a hemoglobin blood substitute
11/25/1997	US5691451 Method for sterilizing recombinant human serum albumin pharmaceutical preparation
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691447 GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
11/25/1997	US5691368 Therapy for neurodegenerative disorders
11/25/1997	US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer
11/25/1997	US5691315 Cardiovascular disorders; vasodilator; bronchodilator
11/25/1997	US5691314 Adjunctive therapy
11/25/1997	US5691313 Methods of treating impotency with ciliary neurotrophic factor
11/25/1997	US5691312 Polypeptide and amino acid for injection
11/25/1997	US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997	US5691310 Methods of treatment using proANF peptides
11/25/1997	US5691309 Reduce fat tissue; polypeptide
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691305 Bone implant composition comprising a porous matrix, bone growth promoter proteins, and phosphotyrosyl protein phosphatase inhibitor
11/25/1997	US5691304 Improved process for preparing polymyxin B/dextran conjugates
11/25/1997	US5691301 Nisin compositions for use as enhanced, broad range bactericides
11/25/1997	US5691200 Culture product
11/25/1997	US5691199 DNA encoding biocidal proteins
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5691183 CD4+ T-lymphoctye proteases and genes encoding said proteases
11/25/1997	US5691182 Use of isolated domains of type IV collagen to modify cell and tissue interactions
11/25/1997	US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/25/1997	US5691160 Elution and quantitative analysis of actin in clots with incubation
11/25/1997	US5691156 Method of inhibiting cell growth with the P2U receptor
11/25/1997	US5691147 Observing complexing of cyclin dependent kinase with a binding protein, use as screening method for inhibitors
11/25/1997	US5690962 Mixing with group 1a compound
11/25/1997	US5690941 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
11/25/1997	US5690933 Administering a non-depleting anti-cd4 monoclonal antibody to treat a disorder mediated by an immune reaction to a self-antigen
11/25/1997	US5690932 Clinical disorders associated with carboxypeptidase E mutation
11/25/1997	US5690931 Method for treating thromboembolic conditions via the use of multiple bolus administration of thrombolytically active proteins
11/25/1997	US5690930 Anticarcinogenic and antipsoriasis agents; viricides
11/25/1997	US5690929 Use of methioninase and chemotherapy agents in chemotherapy
11/25/1997	US5690928 Administering transforming growth factor
11/25/1997	US5690927 Use of neuro-glial fetal cell lines for transplantation therapy
11/25/1997	US5690925 Polypeptide
11/25/1997	US5690905 Peptide-metal ion pharmaceutical labeling method
11/25/1997	CA2099865C Hepatic growth factor receptor is the met proto-oncogene
11/24/1997	CA2205824A1 Pharmaceutical preparation with factor viii procoagulant activity and vwf binding activity
11/23/1997	CA2186303A1 Novel genes encoding antiviral proteins of phytolacca insularis nakai and recombinant microorganisms expressing the same proteins
11/22/1997	CA2205078A1 Novel adenoviral vector for transferring human genes in vivo
11/22/1997	CA2205077A1 Peptides which react with antibody representing the prognostic marker for hiv disease progression
11/20/1997	WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
11/20/1997	WO1997043643A1 Inhibitors of pseudomonas aeruginosa induced mucin production: compositions and treatments for cystic fibrosis patients
11/20/1997	WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
11/20/1997	WO1997043431A1 Vehicle for the transport of molecular substances
11/20/1997	WO1997043426A1 Human protein disulfide isomerase
11/20/1997	WO1997043417A1 Cortistatin: neuropeptides, compositions and methods
11/20/1997	WO1997043416A1 Common gamma chain blocking agents
11/20/1997	WO1997043414A2 A basal cell carcinoma tumor suppressor gene
11/20/1997	WO1997043412A1 Novel agouti-related gene
11/20/1997	WO1997043411A1 T-cell receptor alpha-chain constant-region peptides, processes for producing the peptides, and use thereof
11/20/1997	WO1997043404A2 Ribozyme variants with improved catalytic activity under low magnesium conditions
11/20/1997	WO1997043316A1 Physiologically active molecules with extended half-lives and methods of using same
11/20/1997	WO1997043314A2 Collagen binding protein compositions and methods of use
11/20/1997	WO1997043312A1 Gelatine consisting substantially of polypeptides of the collagens ii, vi, ix, x, xi, xii and xiv, process for preparing the same and use thereof
11/20/1997	WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
11/20/1997	WO1997043310A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	WO1997043309A1 Tsetse thrombin inhibitor
11/20/1997	WO1997043308A1 Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
11/20/1997	WO1997043307A1 Compounds inhibiting the association of the pdgf receptor and phosphatidylinositol 3-kinase and their use
11/20/1997	WO1997043306A1 Neuroactive peptides
11/20/1997	WO1997043305A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds

1 ... 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 ... 3163